| Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 VL Feigin, BA Stark, CO Johnson, GA Roth, C Bisignano, GG Abady, ... The Lancet Neurology 20 (10), 795-820, 2021 | 2998 | 2021 |
| Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019 E Nichols, JD Steinmetz, SE Vollset, K Fukutaki, J Chalek, F Abd-Allah, ... The Lancet Public Health 7 (2), e105-e125, 2022 | 1807 | 2022 |
| Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 GBD Collaborators, VL Feigin, BA Stark, CO Johnson, GA Roth, ... The Lancet Neurology 20 (10), 795-820, 2021 | 1196 | 2021 |
| Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis … JM Kocarnik, K Compton, FE Dean, W Fu, BL Gaw, JD Harvey, ... JAMA oncology 8 (3), 420-444, 2022 | 994 | 2022 |
| Adherence to antiretroviral therapy and virologic failure: a meta-analysis WM Bezabhe, L Chalmers, LR Bereznicki, GM Peterson Medicine 95 (15), e3361, 2016 | 309 | 2016 |
| Barriers and facilitators of adherence to antiretroviral drug therapy and retention in care among adult HIV-positive patients: a qualitative study from Ethiopia WM Bezabhe, L Chalmers, LR Bereznicki, GM Peterson, MA Bimirew, ... PloS one 9 (5), e97353, 2014 | 246 | 2014 |
| The COVID-19 pandemic and healthcare systems in Africa: a scoping review of preparedness, impact and response GA Tessema, Y Kinfu, BA Dachew, AG Tesema, Y Assefa, KA Alene, ... BMJ global health 6 (12), e007179, 2021 | 177 | 2021 |
| The global prevalence and trend of human intestinal carriage of ESBL-producing Escherichia coli in the community YM Bezabih, W Sabiiti, E Alamneh, A Bezabih, GM Peterson, ... Journal of Antimicrobial Chemotherapy 76 (1), 22-29, 2021 | 147 | 2021 |
| In vivo anti-inflammatory activities of leaf extracts of Ocimum lamiifolium in mice model W Mequanint, E Makonnen, K Urga Journal of Ethnopharmacology 134 (1), 32-36, 2011 | 94 | 2011 |
| Global, regional, and national sex-specific burden and control of the HIV epidemic, 1990–2019, for 204 countries and territories: the Global Burden of Diseases Study 2019 D Jahagirdar, MK Walters, A Novotney, ED Brewer, TD Frank, A Carter, ... The Lancet HIV 8 (10), e633-e651, 2021 | 77 | 2021 |
| Comparison of the global prevalence and trend of human intestinal carriage of ESBL-producing Escherichia coli between healthcare and community settings: a … YM Bezabih, A Bezabih, M Dion, E Batard, S Teka, A Obole, N Dessalegn, ... JAC-Antimicrobial Resistance 4 (3), dlac048, 2022 | 37 | 2022 |
| Applying the capability, opportunity, and motivation behaviour model (COM-B) to guide the development of interventions to improve early detection of atrial fibrillation AI Jatau, GM Peterson, L Bereznicki, C Dwan, JA Black, WM Bezabhe, ... Clinical Medicine Insights: Cardiology 13, 1179546819885134, 2019 | 33 | 2019 |
| Extent of poly-pharmacy, occurrence and associated factors of drug-drug interaction and potential adverse drug reactions in Gondar Teaching Referral Hospital, North West Ethiopia E Admassie, T Melese, W Mequanent, W Hailu, BA Srikanth Journal of advanced pharmaceutical technology & research 4 (4), 183-189, 2013 | 33 | 2013 |
| Subnational mapping of HIV incidence and mortality among individuals aged 15–49 years in sub-Saharan Africa, 2000–18: a modelling study B Sartorius, JD VanderHeide, M Yang, EA Goosmann, J Hon, E Haeuser, ... The Lancet HIV 8 (6), e363-e375, 2021 | 32 | 2021 |
| Quality use of medicines in patients with chronic kidney disease RL Castelino, T Saunder, A Kitsos, GM Peterson, M Jose, B Wimmer, ... BMC nephrology 21, 1-9, 2020 | 32 | 2020 |
| Adverse drug reactions and clinical outcomes in patients initiated on antiretroviral therapy: A prospective cohort study from Ethiopia WM Bezabhe, LR Bereznicki, L Chalmers, P Gee, DM Kassie, MA Bimirew, ... Drug safety 38, 629-639, 2015 | 30 | 2015 |
| Oral anticoagulant treatment and the risk of dementia in patients with atrial fibrillation: a population‐based cohort study WM Bezabhe, LR Bereznicki, J Radford, BC Wimmer, MS Salahudeen, ... Journal of the American Heart Association 11 (7), e023098, 2022 | 26 | 2022 |
| Factors associated with first-line antiretroviral treatment failure in adult HIV-positive patients: a case-control study from Ethiopia YM Bezabih, F Beyene, WM Bezabhe BMC Infectious Diseases 19, 1-8, 2019 | 26 | 2019 |
| COVID-19 in Ethiopia: a geospatial analysis of vulnerability to infection, case severity and death KA Alene, YA Gelaw, DM Fetene, DN Koye, YA Melaku, H Gesesew, ... BMJ open 11 (2), e044606, 2021 | 25 | 2021 |
| Ten-year trends in the use of oral anticoagulants in Australian general practice patients with atrial fibrillation WM Bezabhe, LR Bereznicki, J Radford, BC Wimmer, C Curtain, ... Frontiers in Pharmacology 12, 586370, 2021 | 24 | 2021 |
